 Landis could be stripped of the Tour de France title he won in July |
Floyd Landis has put forward his case for the US Anti-Doping Agency to dismiss the doping charges against him. The American tested positive for unusual levels of testosterone after winning stage 17 of this year's Tour de France - an event he went on to win.
Landis' lawyer claims the tests on the 'A' and 'B' urine samples did not meet World Anti-Doping Agency criteria.
The USADA review board are expected to make a recommendation on the case within the week.
The USADA, based on the board's recommendation, will then decide whether to charge Landis with a doping offence.
The levels of testosterone found in Landis were more than twice the legal limit after stage 17.
 | I look forward to restoring my good name |
Landis' lawyer Howard Jacobs said in a statement: "The single testosterone/epitestosterone analysis in this case is replete with fundamental, gross errors." Jacobs also claims that the positive finding on the 'B' sample came from a sample number not assigned to Landis.
Landis, who has repeatedly denied taking performance-enhancing drugs, produced a stunning display on the stage 17 ride to Morzine after struggling on the final climb the day before.
There have been various reasons given for the failed test: dehydration, injections for pain in his hip, natural metabolism or that he drank whisky and beer the night before the stage.
"I did not take testosterone or any other performance-enhancing substance and I'm very happy that the science is confirming my innocence," Landis said in a statement.
"I look forward to restoring my good name so that I can focus on my hip replacement and begin training for next season."
Landis, who was sacked by his Phonak team after the positive drugs test, is facing a two-year ban and the loss of his Tour de France title.
E-mail this to a friend 
Printable version 